Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Crossref DOI link: https://doi.org/10.1186/s12941-015-0090-4
Published Online: 2015-06-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Kevin
Zilbermintz, Leeor
Martchenko, Mikhail
License valid from 2015-06-09
Article History
Received: 3 March 2015
Accepted: 27 May 2015
First Online: 9 June 2015